“…In cell-based assays PR-619 was shown to substantially inhibit the activity of ubiquitin-specific protease, ubiquitin carboxy-terminal hydrolase, OTU, and MJD class DUBs when applied at 20–50 µ M, and exhibited a clear effect at a concentration as low as 5 µ M (Altun et al, 2011). PR-619 has been employed as a tool to investigate the role of ubiquitination in cellular processes including lysosomal degradation (Balut et al, 2011), caspase activation (Crowder et al, 2016), the stability of sirtuin-7 (Pandey and Kumar, 2015), protein aggregate formation (Seiberlich et al, 2012), human immunodeficiency virus replication (Setz et al, 2017), and oocyte maturation (Wang et al, 2017), as well as in the analysis of ubiquitin chain structure (Rana et al, 2017). In addition, PR-619 also inhibited the de-SUMOylating enzyme sentrin-specific protease (SENP) 6 in vitro and leads to accumulation of SUMOylated proteins in cells (Altun et al, 2011; Barry et al, 2018).…”